Guardian Pharmacy reports Q3 EPS , consensus 23c

Reports Q3 revenue $377.4M, consensus $354.2M. “Our first year as a public company has been one of disciplined execution and purposeful growth,” said Fred Burke, President and Chief Executive Officer of Guardian Pharmacy (GRDN) Services. “This quarter again demonstrates the power of our model-combining local clinical and business expertise with the scale and resources of our national platform. We delivered strong organic and acquired growth, solid margin performance, and meaningful cash generation, positioning us well for the remainder of the year and beyond. With this momentum, we are raising our full-year revenue and Adjusted EBITDA guidance.”